Friday, July 10, 2026

biotech · Low Grade Upper Tract Urothelial Cancer

Steba Biotech

Steba Biotech clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Toussus-le-Noble, FR HQ
21 Employees
EMA registrant Type
Company details
Status
Public
HQ
Toussus-le-Noble, FR
Employees
21
Programs
1
Drugs
4
Patents
0
Intelligence · Clinical Programs

Steba Biotech projects

1 ClinicalTrials.gov programs sponsored by Steba Biotech.

Steba Biotech has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. CLIN2001UCM301

    STEBA Biotech S.A

    Low Grade Upper Tract Urothelial Cancer

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Steba Biotech have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.